130 related articles for article (PubMed ID: 25108485)
1. Dysregulated activation of c-Src in gestational trophoblastic disease contributes to its aggressive progression.
Wu W; Wang Y; Xu Y; Liu Y; Wang Y; Zhang H
Placenta; 2014 Oct; 35(10):824-30. PubMed ID: 25108485
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of ASPP2 in choriocarcinoma contributes to increased migratory potential through Src signaling pathway activation.
Mak VC; Lee L; Siu MK; Wong OG; Lu X; Ngan HY; Wong ES; Cheung AN
Carcinogenesis; 2013 Sep; 34(9):2170-7. PubMed ID: 23671128
[TBL] [Abstract][Full Text] [Related]
3. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma.
Zhang HJ; Siu MK; Yeung MC; Jiang LL; Mak VC; Ngan HY; Wong OG; Zhang HQ; Cheung AN
Carcinogenesis; 2011 May; 32(5):765-71. PubMed ID: 21325635
[TBL] [Abstract][Full Text] [Related]
4. FBI-1 Is Overexpressed in Gestational Trophoblastic Disease and Promotes Tumor Growth and Cell Aggressiveness of Choriocarcinoma via PI3K/Akt Signaling.
Mak VC; Wong OG; Siu MK; Wong ES; Ng WY; Wong RW; Chan KK; Ngan HY; Cheung AN
Am J Pathol; 2015 Jul; 185(7):2038-48. PubMed ID: 26093985
[TBL] [Abstract][Full Text] [Related]
5. p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease.
Siu MK; Yeung MC; Zhang H; Kong DS; Ho JW; Ngan HY; Chan DC; Cheung AN
Am J Pathol; 2010 Jun; 176(6):3015-22. PubMed ID: 20413688
[TBL] [Abstract][Full Text] [Related]
6. Impact of the Src inhibitor saracatinib on the metastatic phenotype of a fibrosarcoma (KHT) tumor model.
Dong M; Rice L; Lepler S; Pampo C; Siemann DW
Anticancer Res; 2010 Nov; 30(11):4405-13. PubMed ID: 21115886
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of PDCD4 by deSUMOylation associates with the progression of gestational trophoblastic disease.
Wang YX; Cui L; Wu WB; Quinn MJ; Menon R; Zhao JR; Zhang HJ
Placenta; 2022 Dec; 130():17-24. PubMed ID: 36370491
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous targeting of Src kinase and receptor tyrosine kinase results in synergistic inhibition of renal cell carcinoma proliferation and migration.
Bai L; Yang JC; Ok JH; Mack PC; Kung HJ; Evans CP
Int J Cancer; 2012 Jun; 130(11):2693-702. PubMed ID: 21792888
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of lncRNA OGFRP1 Inhibits Proliferation and Invasion of JEG-3 Cells Via AKT/mTOR Pathway.
Meng Q; Xue H
Technol Cancer Res Treat; 2020; 19():1533033820905823. PubMed ID: 32233835
[TBL] [Abstract][Full Text] [Related]
10. Focal adhesion kinase signaling is necessary for the Cyclosporin A-enhanced migration and invasion of human trophoblast cells.
Tang CL; Zhao HB; Li MQ; Du MR; Meng YH; Li DJ
Placenta; 2012 Sep; 33(9):704-11. PubMed ID: 22766276
[TBL] [Abstract][Full Text] [Related]
11. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight hyaluronan induces migration of human choriocarcinoma JEG-3 cells mediated by RHAMM as well as by PI3K and MAPK pathways.
Mascaró M; Pibuel MA; Lompardía SL; Díaz M; Zotta E; Bianconi MI; Lago N; Otero S; Jankilevich G; Alvarez E; Hajos SE
Histochem Cell Biol; 2017 Aug; 148(2):173-187. PubMed ID: 28365860
[TBL] [Abstract][Full Text] [Related]
13. N-linked α2,6-sialylation of integrin β1 by the sialyltransferase ST6Gal1 promotes cell proliferation and stemness in gestational trophoblastic disease.
Liu J; Dong X; Xie R; Tang Y; Thomas AM; Li S; Liu S; Yu M; Qin H
Placenta; 2024 Apr; 149():18-28. PubMed ID: 38490094
[TBL] [Abstract][Full Text] [Related]
14. Oct4 is epigenetically regulated by methylation in normal placenta and gestational trophoblastic disease.
Zhang HJ; Siu MK; Wong ES; Wong KY; Li AS; Chan KY; Ngan HY; Cheung AN
Placenta; 2008 Jun; 29(6):549-54. PubMed ID: 18440631
[TBL] [Abstract][Full Text] [Related]
15. Combined Src and ER blockade impairs human breast cancer proliferation in vitro and in vivo.
Chen Y; Alvarez EA; Azzam D; Wander SA; Guggisberg N; Jordà M; Ju Z; Hennessy BT; Slingerland JM
Breast Cancer Res Treat; 2011 Jul; 128(1):69-78. PubMed ID: 20669046
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of Src inhibitor saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas.
Cavalloni G; Peraldo-Neia C; Sarotto I; Gammaitoni L; Migliardi G; Soster M; Marchiò S; Aglietta M; Leone F
Mol Cancer Ther; 2012 Jul; 11(7):1528-38. PubMed ID: 22452946
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Src activation with cardiotoxin III blocks migration and invasion of MDA-MB-231 cells.
Tsai PC; Chu CL; Chiu CC; Chang LS; Lin SR
Toxicon; 2013 Nov; 74():56-67. PubMed ID: 23933586
[TBL] [Abstract][Full Text] [Related]
18. Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells.
Hiscox S; Morgan L; Green TP; Barrow D; Gee J; Nicholson RI
Breast Cancer Res Treat; 2006 Jun; 97(3):263-74. PubMed ID: 16333527
[TBL] [Abstract][Full Text] [Related]
19. Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells.
Di Florio A; Capurso G; Milione M; Panzuto F; Geremia R; Delle Fave G; Sette C
Endocr Relat Cancer; 2007 Mar; 14(1):111-24. PubMed ID: 17395980
[TBL] [Abstract][Full Text] [Related]
20. PAI-1 induces Src inhibitor resistance via CCL5 in HER2-positive breast cancer cells.
Fang H; Jin J; Huang D; Yang F; Guan X
Cancer Sci; 2018 Jun; 109(6):1949-1957. PubMed ID: 29601121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
